ROS and Brain Diseases: The Good, the Bad, and the Ugly
Open Access
- 1 January 2013
- journal article
- review article
- Published by Hindawi Limited in Oxidative Medicine and Cellular Longevity
- Vol. 2013, 1-14
- https://doi.org/10.1155/2013/963520
Abstract
The brain is a major metabolizer of oxygen and yet has relatively feeble protective antioxidant mechanisms. This paper reviews the Janus-faced properties of reactive oxygen species. It will describe the positive aspects of moderately induced ROS but it will also outline recent research findings concerning the impact of oxidative and nitrooxidative stress on neuronal structure and function in neuropsychiatric diseases, including major depression. A common denominator of all neuropsychiatric diseases including schizophrenia and ADHD is an increased inflammatory response of the brain caused either by an exposure to proinflammatory agents during development or an accumulation of degenerated neurons, oxidized proteins, glycated products, or lipid peroxidation in the adult brain. Therefore, modulation of the prooxidant-antioxidant balance provides a therapeutic option which can be used to improve neuroprotection in response to oxidative stress. We also discuss the neuroprotective role of the nuclear factor erythroid 2-related factor (Nrf2) in the aged brain in response to oxidative stressors and nanoparticle-mediated delivery of ROS-scavenging drugs. The antioxidant therapy is a novel therapeutic strategy. However, the available drugs have pleiotropic actions and are not fully characterized in the clinic. Additional clinical trials are needed to assess the risks and benefits of antioxidant therapies for neuropsychiatric disorders.Keywords
Funding Information
- Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (80)
This publication has 148 references indexed in Scilit:
- NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administrationGlia, 2013
- Clozapine Protects Dopaminergic Neurons from Inflammation-Induced Damage by Inhibiting Microglial OveractivationJournal of Neuroimmune Pharmacology, 2011
- An Insult-Inducible Vector System Activated by Hypoxia and Oxidative Stress for Neuronal Gene TherapyTranslational Stroke Research, 2011
- Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcomeBrain, Behavior, and Immunity, 2010
- Healthy young women with serotonin transporter SS polymorphism show a pro-inflammatory bias under resting and stress conditionsBrain, Behavior, and Immunity, 2010
- Signal transduction to the permeability transition poreFEBS Letters, 2010
- Mitochondrial calcium and the permeability transition in cell deathBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implicationsBiological Psychiatry, 2008
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary PreventionJama-Journal Of The American Medical Association, 2007